抗菌药物耐药性与患者预后：调整的风险
Antimicrobial resistance and patient outcomes: the hazards of adjustment.
作者信息
Schwaber Mitchell J, Carmeli Yehuda
机构信息
Division of Epidemiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
出版信息
Crit Care. 2006;10(5):164. doi: 10.1186/cc5019.
Abstract
Outcomes studies of infections with resistant bacteria often do not account appropriately for intermediate variables--events in the causal pathway between the exposure and the outcome--when controlling for confounders. We discuss how failure to distinguish between confounders and intermediate variables can bias the analysis, and we address methods of approaching this issue.
摘要
耐药菌感染的结果研究在控制混杂因素时，往往没有恰当地考虑中间变量，即暴露与结果之间因果路径上的事件。我们讨论了未能区分混杂因素和中间变量如何导致分析产生偏差，并阐述了解决该问题的方法。
相似文献
1
Antimicrobial resistance and patient outcomes: the hazards of adjustment.抗菌药物耐药性与患者预后：调整的风险
Crit Care. 2006;10(5):164. doi: 10.1186/cc5019.
2
Optimizing the management of community-acquired respiratory tract infections in the age of antimicrobial resistance.在抗菌药物耐药时代优化社区获得性呼吸道感染的管理。
Expert Rev Anti Infect Ther. 2006 Oct;4(5):821-35. doi: 10.1586/14787210.4.5.821.
3
Antimicrobial resistance prevention initiative--an update: proceedings of an expert panel on resistance.
Am J Infect Control. 2007 Nov;35(9):S1-23; quiz S24-6. doi: 10.1016/j.ajic.2007.08.001.
4
Epidemiology and outcomes of multiple antibiotic-resistant bacterial infection in renal transplantation.肾移植中多重耐药细菌感染的流行病学及转归
Transplant Proc. 2007 Sep;39(7):2222-4. doi: 10.1016/j.transproceed.2007.06.061.
5
Urinary tract infection, uropathogens and antimicrobial resistance in diabetic and nondiabetic patients.糖尿病患者和非糖尿病患者的尿路感染、尿路病原体及抗菌药物耐药性
Diabetes Res Clin Pract. 2009 Jul;85(1):e12-3. doi: 10.1016/j.diabres.2009.04.020. Epub 2009 May 28.
6
The importance and future of antimicrobial surveillance studies.抗菌药物监测研究的重要性与未来。
Clin Infect Dis. 2008 Sep 15;47 Suppl 1:S21-31. doi: 10.1086/590063.
7
Current bacteriology of suppurative otitis: resistant patterns and outcomes analysis.化脓性中耳炎的当前细菌学：耐药模式与结果分析
Otol Neurotol. 2009 Apr;30(3):339-43. doi: 10.1097/MAO.0b013e3181977b6e.
8
Clinical and economic burden of antimicrobial resistance.抗菌药物耐药性的临床和经济负担。
Expert Rev Anti Infect Ther. 2008 Oct;6(5):751-63. doi: 10.1586/14787210.6.5.751.
9
Predictive model of antimicrobial-resistant gram-negative bacteremia at the ED.急诊科耐抗菌药物革兰阴性菌血症的预测模型
Am J Emerg Med. 2007 Jul;25(6):597-607. doi: 10.1016/j.ajem.2006.11.024.
10
Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.慢性阻塞性肺疾病严重急性加重患者中的多重耐药菌：患病率、危险因素及转归
Crit Care Med. 2006 Dec;34(12):2959-66. doi: 10.1097/01.CCM.0000245666.28867.C6.
引用本文的文献
1
Evaluation of the health and healthcare system burden due to antimicrobial-resistant Escherichia coli infections in humans: a systematic review and meta-analysis.评估人源耐抗菌药物大肠埃希菌感染所致健康和医疗保健系统负担：系统评价和荟萃分析。
Antimicrob Resist Infect Control. 2020 Dec 10;9(1):200. doi: 10.1186/s13756-020-00863-x.
2
Does vancomycin resistance increase mortality in Enterococcus faecium bacteraemia after orthotopic liver transplantation? A retrospective study.万古霉素耐药是否会增加肝移植术后粪肠球菌菌血症的死亡率？一项回顾性研究。
Antimicrob Resist Infect Control. 2020 Jan 31;9(1):22. doi: 10.1186/s13756-020-0683-3.
3
Risk factors and survival of patients infected with carbapenem-resistant Klebsiella pneumoniae in a KPC endemic setting: a case-control and cohort study.产碳青霉烯酶肺炎克雷伯菌流行地区感染患者的危险因素和生存情况：病例对照和队列研究。
BMC Infect Dis. 2019 Oct 7;19(1):830. doi: 10.1186/s12879-019-4461-x.
4
Multiple antibiotic resistance as a risk factor for mortality and prolonged hospital stay: A cohort study among neonatal intensive care patients with hospital-acquired infections caused by gram-negative bacteria in Vietnam.多重抗生素耐药性作为死亡和住院时间延长的危险因素：越南新生儿重症监护病房革兰氏阴性菌医院获得性感染患者的队列研究。
PLoS One. 2019 May 8;14(5):e0215666. doi: 10.1371/journal.pone.0215666. eCollection 2019.
5
Association between infections caused by multidrug-resistant gram-negative bacteria and mortality in critically ill patients.多重耐药革兰阴性菌感染与危重症患者死亡率之间的关联。
World J Crit Care Med. 2016 May 4;5(2):111-20. doi: 10.5492/wjccm.v5.i2.111.
6
Modified Hodge test: A simple and effective test for detection of carbapenemase production.改良 Hodge 试验：一种用于检测碳青霉烯酶产生的简单有效试验。
Iran J Microbiol. 2011 Dec;3(4):189-93.
7
Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes.多重耐药鲍曼不动杆菌对临床结局的影响。
Eur J Clin Microbiol Infect Dis. 2007 Nov;26(11):793-800. doi: 10.1007/s10096-007-0371-8.
8
Attributable mortality of Acinetobacter baumannii: no longer a controversial issue.鲍曼不动杆菌的归因死亡率：不再是一个有争议的问题。
Crit Care. 2007;11(3):134. doi: 10.1186/cc5911.
本文引用的文献
1
2
Fluoroquinolone-resistant Pseudomonas aeruginosa: assessment of risk factors and clinical impact.耐氟喹诺酮铜绿假单胞菌：危险因素评估及临床影响
Am J Med. 2006 Jun;119(6):526.e19-25. doi: 10.1016/j.amjmed.2005.11.029.
3
Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae.产超广谱β-内酰胺酶肠杆菌科细菌血症的临床和经济影响
Antimicrob Agents Chemother. 2006 Apr;50(4):1257-62. doi: 10.1128/AAC.50.4.1257-1262.2006.
4
Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today's critically ill patients.急性生理学与慢性健康状况评估（APACHE）IV：当今危重症患者的医院死亡率评估
Crit Care Med. 2006 May;34(5):1297-310. doi: 10.1097/01.CCM.0000215112.84523.F0.
5
Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary Health Region: importance of metallo-beta-lactamase (MBL)-producing strains.卡尔加里健康区域耐碳青霉烯类铜绿假单胞菌感染的基于人群的流行病学研究：产金属β-内酰胺酶（MBL）菌株的重要性
J Infect Dis. 2005 Nov 1;192(9):1606-12. doi: 10.1086/444469. Epub 2005 Sep 26.
6
Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis.耐万古霉素与万古霉素敏感肠球菌血流感染相关死亡率的比较：一项荟萃分析。
Clin Infect Dis. 2005 Aug 1;41(3):327-33. doi: 10.1086/430909. Epub 2005 Jun 28.
7
Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment.铜绿假单胞菌血流感染：恰当初始抗菌治疗的重要性
Antimicrob Agents Chemother. 2005 Apr;49(4):1306-11. doi: 10.1128/AAC.49.4.1306-1311.2005.
8
Increased serum resistance in Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases.产超广谱β-内酰胺酶的肺炎克雷伯菌菌株血清耐药性增加。
Antimicrob Agents Chemother. 2004 Sep;48(9):3477-82. doi: 10.1128/AAC.48.9.3477-3482.2004.
9
Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.铜绿假单胞菌血症：死亡危险因素及有效抗菌治疗延迟应用对临床结局的影响
Clin Infect Dis. 2003 Sep 15;37(6):745-51. doi: 10.1086/377200. Epub 2003 Aug 23.
10
Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients.革兰氏阴性杆菌耐药菌感染对住院患者预后的影响。
Crit Care Med. 2003 Apr;31(4):1035-41. doi: 10.1097/01.CCM.0000060015.77443.31.
Zotero 插件